Genetic Analysis of Human Breast Cancer

Abstract

The genetic abnormalities that accumulate in tumor cells are potential clues to their evolution. To identify such abnormalities, we have developed RDA (representational difference analysis), a method that selects small restriction fragments present in only one of two genomic DNAs, or present in one in higher copy number. When nearly pure tumor DNA (driver) is used in excess to subtract normal DNA from the same individual (tester), RDA yields fragments deleted in the tumor. When tester and drivers are reversed, RDA yields fragments amplified in tumor DNAs. DNA was extracted from the nuclei of about 20 breast cancer biopsies, sorted into diploid and aneuploid fractions by flow cytometry. From these pairs, we derived probes for about a half dozen loci that appear to undergo homozygous deletion. Some of the loci of deletion are also sites for high frequency loss of heterozygosity. The PTEN tumor suppressor gene was identified from one of these loci. P-TEN encodes a protein and phospholipid phosphatase.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Aug 01, 1998
Accession Number
ADA359174

Entities

People

  • Michael H. Wigler

Organizations

  • Cold Spring Harbor Laboratory

Tags

DTIC Thesaurus Topics

  • Breast Cancer
  • Cell Physiological Processes
  • Cells
  • Chemical Synthesis
  • Chemistry
  • Chromosomes
  • Colon Cancer
  • Dna Sequence Analysis
  • Genetic Structures
  • Genetics
  • Health Services
  • Medical Personnel
  • Neoplasms

Fields of Study

  • Biology

Readers

  • Molecular and genetic basis of cancer.

Technology Areas

  • Biotechnology